Home :: rss feeds :: News

Cancer

Kennesaw State graduate blends arts and science, evolves as researcher - News

Nutrition and Cancer - Fri, 2021-07-30 07:13
Kennesaw State graduate blends arts and science, evolves as researcher  News
Categories: Cancer News

Age and Borders Are No Barriers for Pancreatic Cancer Patient Connections - Pancreatic Cancer News & Stories

Alternative Cancer Treatment - Fri, 2021-07-30 07:10
Age and Borders Are No Barriers for Pancreatic Cancer Patient Connections  Pancreatic Cancer News & Stories
Categories: Cancer News

What Is Soluble Corn Fiber? Nutrition, Uses, and Side Effects - Healthline

Nutrition and Cancer - Fri, 2021-07-30 07:00
What Is Soluble Corn Fiber? Nutrition, Uses, and Side Effects  Healthline
Categories: Cancer News

Healthy Chinese Food: 10 Great Takeout Options - Healthline

Nutrition and Cancer - Fri, 2021-07-30 06:59
Healthy Chinese Food: 10 Great Takeout Options  Healthline
Categories: Cancer News

The butyrate produced by your gut bugs is good for your health - Massive Science

Nutrition and Cancer - Fri, 2021-07-30 05:39
The butyrate produced by your gut bugs is good for your health  Massive Science
Categories: Cancer News

Bristol Myers Squibb Receives European Commission Approval for Opdivo (nivolumab) as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Following Chemoradiotherapy - Business Wire

Alternative Cancer Treatment - Fri, 2021-07-30 04:59
Bristol Myers Squibb Receives European Commission Approval for Opdivo (nivolumab) as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Following Chemoradiotherapy  Business Wire
Categories: Cancer News

Bristol Myers Squibb Receives European Commission Approval for Opdivo (nivolumab) as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Following Chemoradiotherapy - Business Wire

Alternative Cancer Treatment - Fri, 2021-07-30 04:59
Bristol Myers Squibb Receives European Commission Approval for Opdivo (nivolumab) as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Following Chemoradiotherapy  Business Wire
Categories: Cancer News

Bristol Myers Squibb Receives European Commission Approval for Opdivo (nivolumab) as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Following Chemoradiotherapy - Business Wire

Alternative Cancer Treatment - Fri, 2021-07-30 04:59
Bristol Myers Squibb Receives European Commission Approval for Opdivo (nivolumab) as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Following Chemoradiotherapy  Business Wire
Categories: Cancer News

Bristol Myers Squibb Receives European Commission Approval for Opdivo (nivolumab) as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Following Chemoradiotherapy - Business Wire

Alternative Cancer Treatment - Fri, 2021-07-30 04:59
Bristol Myers Squibb Receives European Commission Approval for Opdivo (nivolumab) as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Following Chemoradiotherapy  Business Wire
Categories: Cancer News

These Are The Top Priorities Challenges For New CDER Director Patrizia Cavazzoni MD - Clinical Leader

Alternative Cancer Treatment - Fri, 2021-07-30 04:18
These Are The Top Priorities Challenges For New CDER Director Patrizia Cavazzoni MD  Clinical Leader
Categories: Cancer News

Will Johnson & Johnson Be Hurt by Its Sunscreen Product Recall? - Motley Fool

Carcinogens - Fri, 2021-07-30 04:15
Will Johnson & Johnson Be Hurt by Its Sunscreen Product Recall?  Motley Fool
Categories: Cancer News

Will Johnson & Johnson Be Hurt by Its Sunscreen Product Recall? - Nasdaq

Carcinogens - Fri, 2021-07-30 04:15
Will Johnson & Johnson Be Hurt by Its Sunscreen Product Recall?  Nasdaq
Categories: Cancer News

Will Johnson & Johnson Be Hurt by Its Sunscreen Product Recall? - Motley Fool

Carcinogens - Fri, 2021-07-30 04:15
Will Johnson & Johnson Be Hurt by Its Sunscreen Product Recall?  Motley Fool
Categories: Cancer News

Will Johnson & Johnson Be Hurt by Its Sunscreen Product Recall? - Motley Fool

Carcinogens - Fri, 2021-07-30 04:15
Will Johnson & Johnson Be Hurt by Its Sunscreen Product Recall?  Motley Fool
Categories: Cancer News

Eco Credentials of Kavalan Sunlight Weldable PVC-Free Banner from CMYUK Chosen for Mammoth Art Installation - WhatTheyThink

Carcinogens - Fri, 2021-07-30 04:02
Eco Credentials of Kavalan Sunlight Weldable PVC-Free Banner from CMYUK Chosen for Mammoth Art Installation  WhatTheyThink
Categories: Cancer News

Postmenopause: Impact on weight, hot flashes, and more - Medical News Today

Alternative Cancer Treatment - Fri, 2021-07-30 03:54
Postmenopause: Impact on weight, hot flashes, and more  Medical News Today
Categories: Cancer News

Mixfit opens personalised nutrition intelligence to health experts - NutraIngredients.com

Nutrition and Cancer - Fri, 2021-07-30 02:34
Mixfit opens personalised nutrition intelligence to health experts  NutraIngredients.com
Categories: Cancer News

Former U.S. Senator Carl Levin, leading voice on national security, dead at 87 - Reuters

Alternative Cancer Treatment - Fri, 2021-07-30 02:34
Former U.S. Senator Carl Levin, leading voice on national security, dead at 87  Reuters
Categories: Cancer News

Top 5 Best CBD Oils Reviewed: Top 5 CBD Brands Rankings List - Mercer Island Reporter

Alternative Cancer Treatment - Fri, 2021-07-30 02:30
Top 5 Best CBD Oils Reviewed: Top 5 CBD Brands Rankings List  Mercer Island Reporter
Categories: Cancer News

Community initiative keeps Kenyan women breastfeeding exclusively for longer - The Conversation Africa

Nutrition and Cancer - Fri, 2021-07-30 01:52
Community initiative keeps Kenyan women breastfeeding exclusively for longer  The Conversation Africa
Categories: Cancer News

Syndicate content